ROCHESTER, N.Y. (WROC) — Experts at the Finger Lakes Clinical Research Lab are working on a new study to increase the longevity of COVID-19 boosters.

According to FLCR, the project is being funded by pharmaceutical sponsors, but the organizations for the study were selected — with FLCR being one of 10 selected across the nation to be a part of the project.

Dr. M. Saleem Ismail is the principal investigator at Finger Lakes Clinical Research — Dr. Ismail attributes the selection of FLCR to their previous work on COVID treatment.

“We have experience with COVID vaccines,” Dr. Ismail said. “We did a major study at the start of 2019 to 2020. We were one of the top enrollers so this area has contributed to care in a significant way. “

Researchers at FLCR are looking for healthy volunteers for the study. Those looking to participate must be between ages 19-55 and must have three vaccines already.